Call us free on 0800 862 0373

Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

Exciting new breast cancer drug hailed 'the biggest advance in years'

Published on 18/09/2012

Health insurance patients could have access to a new cancer drug that has been hailed ‘one of the biggest advances’ in breast cancer treatment in years, after it has been rolled out for use in the UK.

In July 2012, the European Commission approved new drug everolimus (marketed as Afinitor) for use in combination with exemestane to treat certain postmenopausal women with advanced breast cancer.

Now the drug has been launched for use throughout the UK. Recently released trial results of Afinitor have led to experts hailing it one of the biggest advances in breast cancer treatment in years. Professor Stephen Johnston of The Royal Marsden Hospital in London said:

"Everolimus has the potential to redefine the way this common form of advanced breast cancer is treated, and importantly offers women an effective alternative to a chemotherapy regime".

Afinitor has been trialled in combination with another drug called exemestane. In the latest trial, those given a dummy pill and exemestane had their tumour growth stalled by 3.2 months on average.

However, those given Afinitor and exemestane had a stalled tumour growth of 7.8 months.

Rather than blocking cancer cells from taking up oestrogen or lowering hormone levels- a process that cancer cells can become resistant to- Afinitor works by targeting other proteins in the cancer cell which control how it works and grows.

Afinitor is available for private prescription in the UK, meaning patients with health insurance could have access to it on their policy. The drug is priced at £2,970 +VAT for a 30 day pack of 10mg tablets.

However, the National Institute for Health and Clinical Excellence (NICE) will have to review the drug before it is made widely available on the NHS, a process which could take years.

Dr Rachel Greig, of the charity Breakthrough Breast Cancer, said the drug was an exciting development. She said: “Everolimus is one of the biggest advances in breast cancer treatment in many years.

“While this is by no means a cure, it could give patients several extra months of good quality of life with their families."

If you want access to cancer drugs like Afinitor on your health insurance, look for a policy with full cancer cover with cover for licensed cancer drugs and treatments.

© ActiveQuote Ltd. 2012

Categories:  Medical
Exciting new breast cancer drug hailed 'the biggest advance in years'Health insurance patients could have access to a new cancer drug that has been hailed ‘one of the biggest advances’ in breast ca    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile

No.1 health insurance broker as rated by customers

A great service from the initial call, to finalising the agreement. I would highly recommend to my family and friends.

Review centre member

Proactive, efficient, and offered me insurance I need. I would say half price I would end up paying if I did it by myself. Many thanks.

Review centre member

Excellent service. Explained everything in detail and really helped to find the right insurance best suited to my needs - which wasn't necessarily the most expensive. 

Review centre member

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...